Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication approved for attention deficit hyperactivity disorder in youngsters and individuals. In Canada, its availability is strictly regulated by https://lisdexamfetaminepharmacy061175.onesmablog.com/lisdexamfetamine-in-canada-a-complete-guide-84768848